Ash Bullement
0000-0001-7091-0972
5 papers found
Refreshing results…
“Don't keep me waiting”: estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes
Cost–effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland
Incorporating external trial data to improve survival extrapolations: a pilot study of the COU-AA-301 trial
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Missing publications? Search for publications with a matching author name.